BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 22354002)

  • 1. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
    Greenberg AJ; Rajkumar SV; Vachon CM
    Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Monoclonal gammopathy of undetermined significance--potential risk factor of multiple myeloma].
    Stelmach-Gołdyś A; Czarkowska-Paczek B
    Przegl Lek; 2012; 69(5):194-6. PubMed ID: 23050415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
    Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
    Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in the distribution of cytogenetic subtypes between multiple myeloma patients with and without a family history of monoclonal gammopathy and multiple myeloma.
    Greenberg AJ; Cousin M; Kumar S; Ketterling RP; Knudson RA; Larson D; Colby C; Scott C; Vachon CM; Vincent Rajkumar S
    Eur J Haematol; 2013 Sep; 91(3):193-195. PubMed ID: 23647020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal Gammopathy of Undetermined Significance: Current Concepts and Future Prospects.
    Seth S; Zanwar S; Vu L; Kapoor P
    Curr Hematol Malig Rep; 2020 Apr; 15(2):45-55. PubMed ID: 32222885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal Gammopathy of Undetermined Significance.
    Gonsalves WI; Rajkumar SV
    Ann Intern Med; 2022 Dec; 175(12):ITC177-ITC192. PubMed ID: 36508741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherited genetic susceptibility to monoclonal gammopathy of unknown significance.
    Weinhold N; Johnson DC; Rawstron AC; Försti A; Doughty C; Vijayakrishnan J; Broderick P; Dahir NB; Begum DB; Hosking FJ; Yong K; Walker BA; Hoffmann P; Mühleisen TW; Langer C; Dörner E; Jöckel KH; Eisele L; Nöthen MM; Hose D; Davies FE; Goldschmidt H; Morgan GJ; Hemminki K; Houlston RS
    Blood; 2014 Apr; 123(16):2513-7; quiz 2593. PubMed ID: 24449210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coinherited genetics of multiple myeloma and its precursor, monoclonal gammopathy of undetermined significance.
    Clay-Gilmour AI; Hildebrandt MAT; Brown EE; Hofmann JN; Spinelli JJ; Giles GG; Cozen W; Bhatti P; Wu X; Waller RG; Belachew AA; Robinson DP; Norman AD; Sinnwell JP; Berndt SI; Rajkumar SV; Kumar SK; Chanock SJ; Machiela MJ; Milne RL; Slager SL; Camp NJ; Ziv E; Vachon CM
    Blood Adv; 2020 Jun; 4(12):2789-2797. PubMed ID: 32569378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
    Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of MGUS in relatives of multiple myeloma cases by clinical and tumor characteristics.
    Clay-Gilmour AI; Kumar S; Rajkumar SV; Rishi A; Kyle RA; Katzmann JA; Murray DL; Norman AD; Greenberg AJ; Larson DR; O'Byrne MM; Slager SL; Vachon CM
    Leukemia; 2019 Feb; 33(2):499-507. PubMed ID: 30201985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of monoclonal gammopathy of undetermined significance in Asia: a viewpoint from nagasaki atomic bomb survivors.
    Iwanaga M; Tomonaga M
    Clin Lymphoma Myeloma Leuk; 2014 Feb; 14(1):18-20. PubMed ID: 24461807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathy of undetermined significance and smoldering myeloma: new insights into pathophysiology and epidemiology.
    Landgren O
    Hematology Am Soc Hematol Educ Program; 2010; 2010():295-302. PubMed ID: 21239809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between metformin use and progression of monoclonal gammopathy of undetermined significance to multiple myeloma in US veterans with diabetes mellitus: a population-based retrospective cohort study.
    Chang SH; Luo S; O'Brian KK; Thomas TS; Colditz GA; Carlsson NP; Carson KR
    Lancet Haematol; 2015 Jan; 2(1):e30-6. PubMed ID: 26034780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
    Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
    Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Diagnosis and Clinical Follow-up of Monoclonal Gammopathy of Undetermined Significance on Survival in Multiple Myeloma.
    Sigurdardottir EE; Turesson I; Lund SH; Lindqvist EK; Mailankody S; Korde N; Björkholm M; Landgren O; Kristinsson SY
    JAMA Oncol; 2015 May; 1(2):168-74. PubMed ID: 26181017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Monoclonal Gammopathy of Undetermined Significance (MGUS): The experience from the specialized registry of hematologic malignancies of Basse-Normandie (France).
    Cabrera Q; Macro M; Hebert B; Cornet E; Collignon A; Troussard X
    Cancer Epidemiol; 2014 Aug; 38(4):354-6. PubMed ID: 24880205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response comparison of multiple myeloma and monoclonal gammopathy of undetermined significance to the same anti-myeloma therapy: a retrospective cohort study.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Cairns DA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Lancet Haematol; 2017 Dec; 4(12):e584-e594. PubMed ID: 29146225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
    Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
    Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.